Wednesday, 18 July 2012

Amag's anemia drug meets late-stage study goal



(Reuters) - Amag Pharmaceuticals Inc said its anemia drug met the main goal of improving hemoglobin levels of patients in a late-stage study that tested the drug in patients with iron deficiency anemia.





via Reuters: Health News Read More Here..

No comments:

Post a Comment